Mumbai, Sept. 19 -- Glenmark Pharmaceuticals announced that CRISIL has reaffirmed the credit rating for the bank loan facilities of Rs 1850 crore availed by the company at CRISIL AA/ CRISIL A1+. The outlook on the rating has been revised from Stable to Positive.

Published by HT Digital Content Services with permission from Capital Market....